What are normal ApoB levels and why do they matter?

Normal ApoB levels are typically under 90 mg/dL for optimal health, though standard ranges go up to 100-130 mg/dL. ApoB is a superior predictor of heart disease risk compared to LDL cholesterol, as it counts all harmful cholesterol particles.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding ApoB: The Heart Health Biomarker You Should Know

If you've been monitoring your cholesterol levels, you're likely familiar with LDL (low-density lipoprotein) cholesterol, often called "bad cholesterol." But there's a more accurate predictor of cardiovascular disease risk that many people haven't heard of: Apolipoprotein B, or ApoB.

ApoB is a protein found on the surface of all potentially harmful cholesterol particles in your blood, including LDL, VLDL (very low-density lipoprotein), IDL (intermediate-density lipoprotein), and Lp(a). Think of it as the delivery truck driver for cholesterol - each harmful particle has exactly one ApoB protein, making it an excellent way to count the total number of atherogenic (artery-clogging) particles in your bloodstream.

Recent research has shown that ApoB levels are a better predictor of heart attack and stroke risk than traditional cholesterol measurements. This is because cardiovascular disease risk depends more on the number of cholesterol particles than the amount of cholesterol they carry. Understanding your ApoB levels through comprehensive testing can provide crucial insights into your cardiovascular health.

ApoB Target Levels by Risk Category

Target levels should be individualized based on complete risk assessment and clinical judgment.
Risk CategoryTarget ApoB LevelKey Risk Factors
Low RiskLow Risk<90 mg/dLNo major risk factors, age <40
Moderate RiskModerate Risk<80 mg/dL1-2 risk factors (hypertension, family history)
High RiskHigh Risk<70 mg/dLDiabetes, metabolic syndrome, or multiple risk factors
Very High RiskVery High Risk<60 mg/dLEstablished cardiovascular disease or recent cardiac event

Target levels should be individualized based on complete risk assessment and clinical judgment.

What Are Normal ApoB Levels?

ApoB levels are measured in milligrams per deciliter (mg/dL) of blood. The reference ranges can vary slightly between laboratories and medical organizations, but here are the generally accepted guidelines:

Standard Reference Ranges

  • Normal: Less than 100 mg/dL
  • Borderline high: 100-129 mg/dL
  • High: 130 mg/dL and above

However, many cardiovascular health experts and preventive cardiologists recommend aiming for even lower levels for optimal heart health:

  • Optimal: Less than 80-90 mg/dL
  • For high-risk individuals: Less than 70 mg/dL
  • For very high-risk individuals with established cardiovascular disease: Less than 60 mg/dL

Factors That Influence Your Target Range

Your ideal ApoB level depends on several factors, including your overall cardiovascular risk profile. People with diabetes, metabolic syndrome, family history of early heart disease, or existing cardiovascular conditions may need to maintain lower ApoB levels than the general population.

Age and gender also play a role. ApoB levels tend to increase with age, and post-menopausal women often see a rise in their levels due to hormonal changes. Understanding these risk categories helps determine your optimal target range.

Why ApoB Matters More Than LDL Cholesterol

For decades, LDL cholesterol has been the primary marker for assessing cardiovascular risk. However, LDL-C measurements have a significant limitation: they measure the amount of cholesterol within LDL particles, not the number of particles themselves.

The Particle Number Problem

Two people can have identical LDL cholesterol levels but vastly different numbers of LDL particles. Person A might have fewer, larger LDL particles carrying the same amount of cholesterol as Person B's numerous small, dense particles. Since each particle - regardless of size - can penetrate arterial walls and contribute to plaque formation, Person B faces higher cardiovascular risk despite having the same LDL-C level.

ApoB solves this problem by counting particles rather than measuring cholesterol content. Since each atherogenic particle contains exactly one ApoB protein, your ApoB level directly reflects the number of potentially harmful particles circulating in your blood.

Superior Risk Prediction

Multiple large-scale studies have demonstrated ApoB's superiority in predicting cardiovascular events. A 2021 analysis of over 389,000 individuals found that ApoB was the strongest lipid predictor of myocardial infarction risk. The study showed that people with high ApoB but normal LDL-C still faced increased cardiovascular risk, highlighting the importance of measuring both markers.

Health Risks of Elevated ApoB

High ApoB levels indicate an increased number of atherogenic particles in your bloodstream, which can lead to several serious health complications:

Atherosclerosis Development

When ApoB-containing particles penetrate the arterial wall, they can become trapped and oxidized, triggering an inflammatory response. This process leads to the formation of atherosclerotic plaques, which narrow arteries and restrict blood flow. Over time, these plaques can rupture, causing heart attacks or strokes.

Increased Cardiovascular Event Risk

Research shows that for every 10 mg/dL increase in ApoB levels, the risk of coronary heart disease increases by approximately 10-15%. People with ApoB levels above 120 mg/dL face a significantly higher risk of experiencing a cardiovascular event within the next 10 years compared to those with levels below 80 mg/dL.

  • Heart attack (myocardial infarction)
  • Stroke
  • Peripheral artery disease
  • Sudden cardiac death
  • Need for cardiac procedures like stenting or bypass surgery

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

How to Test Your ApoB Levels

Testing your ApoB levels requires a simple blood draw, typically done after fasting for 9-12 hours. While not all standard lipid panels include ApoB, it's becoming increasingly available as more healthcare providers recognize its importance.

When to Get Tested

The frequency of ApoB testing depends on your risk factors and current levels. General recommendations include:

  • Adults over 20: Baseline testing, then every 4-6 years if levels are optimal
  • Adults over 40 or with risk factors: Every 1-2 years
  • Those with elevated levels or on treatment: Every 3-6 months until goals are met
  • People with diabetes or established heart disease: At least annually

Regular monitoring is especially important if you're making lifestyle changes or taking medications to lower your ApoB levels. Comprehensive cardiovascular testing that includes ApoB alongside traditional markers provides the most complete picture of your heart health.

Understanding Your Results

When you receive your ApoB results, they should be interpreted in the context of your other cardiovascular risk factors. Your healthcare provider will consider your age, blood pressure, smoking status, family history, and other biomarkers to determine your overall risk and appropriate target levels.

If you have existing blood test results that don't include ApoB, you can upload them to SiPhox Health's free analysis service to get personalized insights and recommendations for additional testing that might benefit your health optimization journey.

Strategies to Optimize Your ApoB Levels

The good news is that ApoB levels respond well to both lifestyle interventions and medical treatments. Here's how you can work to improve your levels:

Dietary Modifications

Your diet plays a crucial role in managing ApoB levels. Focus on:

  • Reducing saturated fat intake to less than 7% of total calories
  • Eliminating trans fats completely
  • Increasing soluble fiber intake (oats, beans, apples, barley)
  • Adding plant sterols and stanols (2-3 grams daily)
  • Incorporating omega-3 fatty acids from fish or supplements
  • Following a Mediterranean-style diet pattern

Studies show that dietary changes alone can reduce ApoB levels by 5-20%, depending on baseline diet quality and adherence to recommendations.

Exercise and Physical Activity

Regular physical activity helps lower ApoB through multiple mechanisms, including improved insulin sensitivity and enhanced lipid metabolism. Aim for:

  • At least 150 minutes of moderate-intensity aerobic exercise weekly
  • Two or more days of resistance training
  • High-intensity interval training (HIIT) for additional benefits
  • Daily movement and avoiding prolonged sitting

Medical Interventions

When lifestyle changes aren't sufficient, medications can effectively lower ApoB levels. Statins remain the first-line therapy, typically reducing ApoB by 30-50%. Other options include ezetimibe, PCSK9 inhibitors, and newer medications like bempedoic acid. Your healthcare provider can help determine the best approach based on your individual risk profile and response to treatment.

The Future of Cardiovascular Risk Assessment

As our understanding of cardiovascular disease evolves, ApoB is increasingly recognized as a critical biomarker for risk assessment and management. Many leading cardiologists now consider it the single best lipid marker for predicting cardiovascular events.

The shift toward ApoB-focused assessment represents a more precise approach to cardiovascular health. By counting atherogenic particles rather than estimating cholesterol content, we can better identify at-risk individuals and tailor interventions more effectively.

Professional organizations are beginning to incorporate ApoB into their guidelines, and it's likely to become a standard part of cardiovascular risk assessment in the coming years. Staying ahead of this curve by monitoring your ApoB levels now can give you a significant advantage in preventing heart disease.

Taking Control of Your Cardiovascular Health

Understanding and optimizing your ApoB levels is a powerful step toward preventing cardiovascular disease. While traditional cholesterol measurements provide valuable information, ApoB offers a more complete picture of your cardiovascular risk by counting the particles that actually cause atherosclerosis.

Whether your ApoB levels are currently optimal or need improvement, regular monitoring combined with appropriate lifestyle modifications can help you maintain cardiovascular health for years to come. Remember that small, consistent changes often yield the most sustainable results.

By taking a proactive approach to managing your ApoB levels through comprehensive testing, healthy lifestyle choices, and working with your healthcare team, you're investing in a future with a stronger, healthier heart. The science is clear: when it comes to predicting and preventing cardiovascular disease, ApoB matters.

References

  1. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295.[Link][PubMed][DOI]
  2. Welsh C, Celis-Morales CA, Brown R, et al. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease. Circulation. 2019;140(7):542-552.[Link][PubMed][DOI]
  3. Marston NA, Giugliano RP, Melloni GEM, et al. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis. JAMA Cardiol. 2022;7(3):250-256.[Link][PubMed][DOI]
  4. Langlois MR, Nordestgaard BG, Langsted A, et al. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM. Clin Chem Lab Med. 2020;58(4):496-517.[Link][PubMed][DOI]
  5. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188.[Link][PubMed][DOI]
  6. Johannesen CDL, Mortensen MB, Langsted A, Nordestgaard BG. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients. J Am Coll Cardiol. 2021;77(11):1439-1450.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ApoB at home?

You can test your ApoB at home with SiPhox Health's Apob Advanced Cholesterol Panel or the comprehensive Heart & Metabolic Program. Both options include ApoB testing along with other important cardiovascular markers, providing lab-quality results from the comfort of your home.

What's the difference between ApoB and LDL cholesterol?

LDL cholesterol measures the amount of cholesterol within LDL particles, while ApoB counts the actual number of all atherogenic particles (including LDL, VLDL, IDL, and Lp(a)). Since each harmful particle has one ApoB protein, ApoB provides a more accurate count of particles that can cause atherosclerosis, making it a better predictor of cardiovascular risk.

Can I lower my ApoB levels naturally without medication?

Yes, many people can lower ApoB levels through lifestyle changes. Dietary modifications like reducing saturated fat, increasing soluble fiber, and following a Mediterranean diet can reduce levels by 5-20%. Regular exercise, weight loss, and managing blood sugar also help. However, some individuals may need medication to reach optimal levels, especially if they have genetic predispositions or very high baseline levels.

How often should I check my ApoB levels?

Testing frequency depends on your risk factors and current levels. If your levels are optimal and you have no risk factors, testing every 4-6 years may be sufficient. Those with elevated levels, on treatment, or with cardiovascular risk factors should test every 3-6 months until goals are met, then annually. People with diabetes or heart disease should test at least yearly.

Is ApoB included in standard cholesterol tests?

No, ApoB is not typically included in standard lipid panels that only measure total cholesterol, LDL-C, HDL-C, and triglycerides. You need to specifically request ApoB testing or choose comprehensive cardiovascular panels that include this important marker. Many preventive cardiologists now recommend including ApoB in routine cardiovascular risk assessment.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details